Corrigendum to “Asundexian in atrial fibrillation – Can pharmacodynamic data explain the failure?” [Thromb. Res. 236 (2024) 236–239 TR_8963]
Corrigendum to “Asundexian in atrial fibrillation – Can pharmacodynamic data…
Ler MaisProthrombotic plasma fibrin clot phenotype is associated with spontaneous echo contrast in atrial fibrillation: The role of protein carbonylation
Prothrombotic plasma fibrin clot phenotype is associated with spontaneous echo…
Ler MaisAnticoagulation for Stroke Prevention in Atrial Fibrillation and Treatment of Venous Thromboembolism and Portal Vein Thrombosis in Cirrhosis: Guidance from the SSC of the ISTH
Anticoagulation for Stroke Prevention in Atrial Fibrillation and Treatment of…
Ler MaisObese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials
Obese patients with atrial fibrillation are more efficiently protected from…
Ler MaisDOACs for Older adults with Atrial Fibrillation and Falls: Results from the prospective single-centre DOAFF study
DOACs for Older adults with Atrial Fibrillation and Falls: Results…
Ler Mais